Medindia

X

2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation

Tuesday, November 6, 2007 General News J E 4
Advertisement
CAMBRIDGE, Mass., Nov. 5 MillenniumPharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation atthe 2007 Credit Suisse Healthcare Conference will be webcast live and may beaccessed by visiting the Investors section of the Company's website,http://www.millennium.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The presentation will include an overview of the Company, an update onclinical trials for VELCADE(R) (bortezomib) for Injection and other productcandidates, and a review of upcoming milestones. The presentation will bedelivered at 1:00 p.m. ET on Tuesday, November 13, 2007 from the ArizonaBiltmore Resort in Phoenix, Arizona. The presentation will be archived for 30days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical companybased in Cambridge, Mass., markets VELCADE, a novel cancer product, and has arobust clinical development pipeline of product candidates. The Company'sresearch, development and commercialization activities are focused in twotherapeutic areas: oncology and inflammation. By applying its knowledge ofthe human genome, understanding of disease mechanisms and industrialized drugdiscovery platform, Millennium is developing an exciting pipeline ofinnovative product candidates. The Company's website ishttp://www.millennium.com.

Editors' Note: This press release is also available under the Mediasection of the Company's website at: http://www.millennium.com.

Contact:

Kyle Kuvalanka

(617) 761-4734

SOURCE Millennium Pharmaceuticals, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
American Oriental Bioengineering Reports Third Qua...
S
HealthSouth Reports Results for Third Quarter Ende...